For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
Synthetic peptide corresponding to residues near the C-terminal of human Dishevelled 3.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
An immunizing peptide is available for this antibody as ab191381.
Our Abpromise guarantee covers the use of ab76081 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/500 - 1/1000. Predicted molecular weight: 78 kDa.Can be blocked with Dishevelled 3 peptide (ab191381).|
|ICC||1/100 - 1/250.|
|IHC-P||Use at an assay dependent dilution.|
|ICC/IF||Use a concentration of 5 µg/ml.|
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"